Steward Partners Investment Advisory »

Theravance Biopharma shares owned by Steward Partners Investment Advisory

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Steward Partners Investment Advisory from 13F filings

Historical chart of Steward Partners Investment Advisory investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Steward Partners Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Steward Partners Investment Advisory

Quarter filed Position value Share count Share price at filing
2024-03-31 $14k 1.5k 8.97
2020-09-30 $7.0k 500 14.00
2020-06-30 $10k 500 20.00
2020-03-31 $11k 500 22.00

More positions owned by Steward Partners Investment Advisory

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core Us Aggbd Et (AGG)
Home Depot (HD)
Ishares Tr Rus 1000 Grw Etf (IWF)
Wisdomtree Tr Us Qtly Div Grt (DGRW)

View all positions for Steward Partners Investment Advisory

Top funds holding Theravance Biopharma

Weiss Asset Management LP[1
Madison Avenue Partners
BlackRock
Irenic Capital Management
Vanguard Group
Pictet Asset Management Holding SA
Newtyn Management
Oasis Management
Park West Asset Management
Geode Capital Management
D. E. Shaw & Co
Jacobs Levy Equity Management
Bank of America Corporation
Northern Trust
Morgan Stanley

View all funds holding Theravance Biopharma